Table 2. Susceptibility profile of MDR Enterobacterales and Pseudomonas aeruginosa for CZA.

CZA: ceftazidime/avibactam; CRO: carbapenem-resistant organisms; CSO: carbapenem-susceptible organisms; MDR: multidrug-resistant.

Organisms	CZA susceptibility among CRO (%(n/N))	CZA susceptibility among CSO  (%(n/N))	CZA susceptibility among MDR Isolates  (%(n/N))
Enterobacterales	24.1% (61 /253)	92.5% (37/40)	33.4% (98/293)
Escherichia coli	3.2% (2 /63)	91.7% (22/24)	27.5% (24/87)
Klebsiella pneumoniae	33.5% (58/173)	91.7% (11/12)	37.3% (69/185)
Enterobacter cloacae	8.3% (1 /12)	100% (4/4)	31.2% (5/16)
Others	0% (0 /5)	0 (0/0)	0% (0/5)
Pseudomonas aeruginosa	0% (0/30)	100% (1/1)	3.2% (1/31)
Total	21.6% (61/283)	92.7% (38/41)	30.6% (99/324)